Financing type:  registered direct prospectus offering

Gross proceeds:  $25-million (U.S.)

Offering:  five million listed shares with five million warrants

Offering price:  $5 (U.S.) ($6.86 (Canadian)) per listed share

Warrant exercise terms:  $8.16 (Canadian) per listed share for a five-year period

Disclosure:  Refer to the prospectus supplement dated July 17, 2025, to the short form base shelf prospectus dated Sept. 6, 2024, and the company's news releases dated July 7, 2025, and July 17, 2025.